Sign Up
Sign up for all the latest news, offers and to check-out even faster.
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349875/
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/
Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979781/
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958190/
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690292/
Review of the neurological benefits of phytocannabinoids
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938896/
Hsiao YT, Yi PL, Li CL, Chang FC. Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology. 2012 Jan;62(1):373–84. DOI:
http://dx.doi.org/10.1016/j.neuropharm.2011.08.013. [PubMed]
Crippa JA, Derenusson GN, Ferrari TB, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011 Jan;25(1):121–30. DOI:
http://dx.doi.org/10.1177/0269881110379283. [PubMed]
Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3364–78. DOI:
http://dx.doi.org/10.1098/rstb.2011.0389.
Lee MA. CBD: how it works. O’Shaughnessy’s [Internet] 2011. Autumn. [cited 2016 Apr 26]:14. Available from:
www.os-extra.cannabisclinicians.org/wp-content/uploads/2012/07/CBDiary21.pdf.
Zhornitsky S, Potvin S. Cannabidiol in humans—the quest for therapeutic targets. Pharmaceuticals (Basel) 2012 May 21;5(5):529–52. DOI:
http://dx.doi.org/10.3390/ph5050529. [PMC free article][PubMed]